Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-06-13
1978-05-09
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424305, A61K 3119, A61K 31215
Patent
active
040887847
ABSTRACT:
The present invention provides a method for treatment of Crohn's disease, inflammatory bowel disease, infectious enteritis, sprue, and intestinal inflammatory disease secondary to radiation exposure or an intestinally-manifested allergic response to foodstuffs which comprises administrating a cytoprotective prostaglandin to a human who suffers from one of said diseases. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "non-steroidal antiinflammatory compound".
REFERENCES:
patent: 3927213 (1975-12-01), Lippmann
patent: 3928588 (1975-12-01), Robert
Armitage Robert A.
Rosen Sam
The Upjohn Company
LandOfFree
Cytoprotective prostaglandins for use in radiation-induced human does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytoprotective prostaglandins for use in radiation-induced human, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytoprotective prostaglandins for use in radiation-induced human will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358123